First-in-class mast cell selective c-Kit inhibitor enters clinical testing in Germany

SBT-77-7101 shows favourable safety and early signs of efficacy in patients with refractory RA

Faster scans and same-day results improve patient experience across community sites

New data support European filing for nonsteroidal topical treatment

Domain Therapeutics has announced the first patients have been dosed in its phase 1/2 DOMISOL clinical trial of […]

$25m milestone payment supports pipeline progress in neurodegenerative disease research

Qureight’s imaging platform validated in peer-reviewed study

Exclusive licensing deal aims to advance promising cancer therapy

Preliminary phase 4 data highlights improvements in sleep, work productivity and quality of life

International registry highlights impact of POTELIGEO in rare lymphoma subtypes